1mk3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1mk3" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mk3" /> '''SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN''...)
Line 1: Line 1:
-
[[Image:1mk3.gif|left|200px]]<br />
+
[[Image:1mk3.gif|left|200px]]<br /><applet load="1mk3" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1mk3" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1mk3" />
caption="1mk3" />
'''SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN'''<br />
'''SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN'''<br />
==Overview==
==Overview==
-
The structure of human BCL-w, an anti-apoptotic member of the BCL-2, family, was determined by triple-resonance NMR spectroscopy and molecular, modeling. Introduction of a single amino acid substitution (P117V), significantly improved the quality of the NMR spectra obtained. The, cytosolic domain of BCL-w consists of 8 alpha-helices, which adopt a fold, similar to that of BCL-xL, BCL-2, and BAX proteins. Pairwise root meant, square deviation values were less than 3 A for backbone atoms of, structurally equivalent regions. Interestingly, the C-terminal helix, alpha8 of BCL-w folds into the BH3-binding hydrophobic cleft of the, protein, in a fashion similar to the C-terminal transmembrane helix of, BAX. A peptide corresponding to the BH3 region of the pro-apoptotic, protein, BID, could displace helix alpha8 from the BCL-w cleft, resulting, in helix unfolding. Deletion of helix alpha8 increased binding affinities, of BCL-w for BAK and BID BH3-peptides, indicating that this helix competes, for peptide binding to the hydrophobic cleft. These results suggest that, although the cytosolic domain of BCL-w exhibits an overall structure, similar to that of BCL-xL and BCL-2, the unique organization of its, C-terminal helix may modulate BCL-w interactions with pro-apoptotic, binding partners.
+
The structure of human BCL-w, an anti-apoptotic member of the BCL-2 family, was determined by triple-resonance NMR spectroscopy and molecular modeling. Introduction of a single amino acid substitution (P117V) significantly improved the quality of the NMR spectra obtained. The cytosolic domain of BCL-w consists of 8 alpha-helices, which adopt a fold similar to that of BCL-xL, BCL-2, and BAX proteins. Pairwise root meant square deviation values were less than 3 A for backbone atoms of structurally equivalent regions. Interestingly, the C-terminal helix alpha8 of BCL-w folds into the BH3-binding hydrophobic cleft of the protein, in a fashion similar to the C-terminal transmembrane helix of BAX. A peptide corresponding to the BH3 region of the pro-apoptotic protein, BID, could displace helix alpha8 from the BCL-w cleft, resulting in helix unfolding. Deletion of helix alpha8 increased binding affinities of BCL-w for BAK and BID BH3-peptides, indicating that this helix competes for peptide binding to the hydrophobic cleft. These results suggest that although the cytosolic domain of BCL-w exhibits an overall structure similar to that of BCL-xL and BCL-2, the unique organization of its C-terminal helix may modulate BCL-w interactions with pro-apoptotic binding partners.
==About this Structure==
==About this Structure==
-
1MK3 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MK3 OCA].
+
1MK3 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MK3 OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Beauparlant, P.]]
[[Category: Beauparlant, P.]]
[[Category: Chen, G.]]
[[Category: Chen, G.]]
-
[[Category: Denisov, A.Y.]]
+
[[Category: Denisov, A Y.]]
[[Category: Gehring, K.]]
[[Category: Gehring, K.]]
[[Category: Khadir, A.]]
[[Category: Khadir, A.]]
-
[[Category: Madiraju, M.S.]]
+
[[Category: Madiraju, M S.]]
-
[[Category: Shore, G.C.]]
+
[[Category: Shore, G C.]]
[[Category: apoptotis]]
[[Category: apoptotis]]
[[Category: bcl-w protein]]
[[Category: bcl-w protein]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:12:22 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:55:59 2008''

Revision as of 11:55, 21 February 2008


1mk3

Drag the structure with the mouse to rotate

SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN

Overview

The structure of human BCL-w, an anti-apoptotic member of the BCL-2 family, was determined by triple-resonance NMR spectroscopy and molecular modeling. Introduction of a single amino acid substitution (P117V) significantly improved the quality of the NMR spectra obtained. The cytosolic domain of BCL-w consists of 8 alpha-helices, which adopt a fold similar to that of BCL-xL, BCL-2, and BAX proteins. Pairwise root meant square deviation values were less than 3 A for backbone atoms of structurally equivalent regions. Interestingly, the C-terminal helix alpha8 of BCL-w folds into the BH3-binding hydrophobic cleft of the protein, in a fashion similar to the C-terminal transmembrane helix of BAX. A peptide corresponding to the BH3 region of the pro-apoptotic protein, BID, could displace helix alpha8 from the BCL-w cleft, resulting in helix unfolding. Deletion of helix alpha8 increased binding affinities of BCL-w for BAK and BID BH3-peptides, indicating that this helix competes for peptide binding to the hydrophobic cleft. These results suggest that although the cytosolic domain of BCL-w exhibits an overall structure similar to that of BCL-xL and BCL-2, the unique organization of its C-terminal helix may modulate BCL-w interactions with pro-apoptotic binding partners.

About this Structure

1MK3 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix., Denisov AY, Madiraju MS, Chen G, Khadir A, Beauparlant P, Attardo G, Shore GC, Gehring K, J Biol Chem. 2003 Jun 6;278(23):21124-8. Epub 2003 Mar 21. PMID:12651847

Page seeded by OCA on Thu Feb 21 13:55:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools